Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Treat to target"'
Autor:
Bastiaan T. van Dijk, Sytske Anne Bergstra, J. Merlijn van den Berg, Dieneke Schonenberg-Meinema, Lisette W.A. van Suijlekom-Smit, Marion A.J. van Rossum, Yvonne Koopman-Keemink, Rebecca ten Cate, Cornelia F. Allaart, Daniëlle M.C. Brinkman, Petra C.E. Hissink Muller
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 22, Iss 1, Pp 1-9 (2024)
Abstract Background Etanercept has been studied in doses up to 0.8 mg/kg/week (max 50 mg/week) in juvenile idiopathic arthritis (JIA) patients. In clinical practice higher doses are used off-label, but evidence regarding the relation with outcomes is
Externí odkaz:
https://doaj.org/article/fa8d9324980a49eb9888c4d773ba6e32
Autor:
Y El Miedany, M El Gaafary, M Toth, A Abdel Azim, D Palmer, G Dolbear, D Affam, W Hassan, SA Tabra, S Saber, MH Abu-zaid
Publikováno v:
Egyptian Rheumatology and Rehabilitation, Vol 51, Iss 1, Pp 1-17 (2024)
Abstract Background The aim of this work is to develop guidelines for health care professionals in the giant cell arteritis diagnosis and management, based on patients’ stratification and targeted outcome measures. Results Fourteen expert panel had
Externí odkaz:
https://doaj.org/article/7170df546dba47729a1014a10e80d485
Autor:
Agner R. Parra Sánchez, Ronald F. van Vollenhoven, Eric F. Morand, Ian N. Bruce, Rangi Kandane-Rathnayake, Gudrun Weiss, Raj Tummala, Hussein Al-Mossawi, Alessandro Sorrentino
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 6, Pp 1459-1477 (2023)
Abstract Remission is the established therapeutic goal for patients with systemic lupus erythematosus (SLE) and is currently defined by the widely adopted Definition Of Remission In SLE (DORIS) criteria. Attainment of remission is rare in the clinica
Externí odkaz:
https://doaj.org/article/e1fcf1e203f84ba88cc0a6c10e3a1017
Autor:
Louis Bessette, Boulos Haraoui, Emmanouil Rampakakis, Joanna Dembowy, Marc-Olivier Trépanier, Janet Pope
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-13 (2023)
Abstract Background To compare a treat-to-target (T2T) approach and routine care (RC) in adults with active to severely active rheumatoid arthritis (RA) initiating subcutaneous abatacept. Methods A 12-month cluster-randomized trial in active RA patie
Externí odkaz:
https://doaj.org/article/5012c58ad7594116a451188357184c8a
Publikováno v:
Global Rheumatology, Vol 5 (2024)
Introduction: Certolizumab pegol (CTZ) is a tumor necrosis factor-alpha (TNF-α) inhibitor biological agent that has demonstrated efficacy in controlling rheumatoid arthritis (RA). Identifying predictive factors for treatment success and assessing it
Externí odkaz:
https://doaj.org/article/b305c80268e448d7bebf1f4a89ee17f6
Autor:
Walter P. Maksymowych, Robert D. Inman, Louis Bessette, Proton Rahman, Emmanouil Rampakakis, Odalis Asin-Milan, Meagan Rachich, Anne Marilise Marrache, Allen J. Lehman
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-9 (2023)
Abstract Objectives To (i) determine whether sustained disease activity states, as measured by Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS), impact function, and (ii) evaluate c
Externí odkaz:
https://doaj.org/article/9279f4b69de74911a73889114a9b86b8
Autor:
Yasser El Miedany, Khaled Elhadidi, Geilan Abdelmoneim Mahmoud, Mohammed Hassan Abu-Zaid, Atef Abdelazim Mahmoud, Maha El Gaafary, Nadia Kamel, Nihal Ahmed Fathi, Ahmed Abdel Nasser, Waleed Hassan, Mervat Eissa, Eman Sarhan, Essam Aboalfadl, Ahmed Ezzat Mansour, Mohamed Mortada, Nermeen Ahmed Fouad, Ismail Elaraby, Rehab Elnemr, Basma M. Medhat, Sally S. Mohamed, Rehab Ali Ibrahim, Samar abd Alhamed Tabra, Sally Saber, Genny Franklin, Abir Mokbel
Publikováno v:
Egyptian Rheumatology and Rehabilitation, Vol 50, Iss 1, Pp 1-19 (2023)
Abstract Background Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease characterized by having varying clinical presentation, severity, unpredictable course as well as outcomes. Recent disease-modifying conventional and biolo
Externí odkaz:
https://doaj.org/article/25877d493b5445c9923cd0e7182a2ed8
Autor:
E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, P. O. Tremaskina, S. I. Glukhova, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 5, Pp 580-586 (2022)
Aim – to study 2 years outcomes of the treat-to-target (T2T) strategy in early psoriatic arthritis (ePsA) patients. Material and methods. 68 (33 male/35 female) ePsA patients according to CASPAR criteria (mean age – 37.3±10.8 years; PsA duration
Externí odkaz:
https://doaj.org/article/a89561342d02406791040d39d2ed3f60
Autor:
Yasser El Miedany, Mohammed Hassan Abu-Zaid, Maha El Gaafary, Mona Mansour, Nihal Fathy, Waleed Hassan, Mohamed Mortada, Mervat Eissa, Samar Abdelhamed Tabra, Salwa Galal, Nermeen Foad, Rehab Ali Ibrahim, Basma Medhat, Gehan El Olemy, Yasmin Adel, Rasha Ghaleb, Sally Saber, Naglaa GadAllah
Publikováno v:
Egyptian Rheumatology and Rehabilitation, Vol 49, Iss 1, Pp 1-16 (2022)
Abstract Background Busy rheumatologists, and busy patients as well as policy makers, require accurate, succinct, transparent, easily digested summaries of evidence and recommendations for management. Our objective was to develop an up-to-date eviden
Externí odkaz:
https://doaj.org/article/e01afc418f1448ca8088ad4f3aff51b2
Publikováno v:
BMC Rheumatology, Vol 6, Iss 1, Pp 1-10 (2022)
Abstract Background A treat-to-target (T2T) approach, where treatment is escalated until a specific target is achieved, and re-escalated if the target is lost, has been proposed as a strategy to improve Childhood Systemic Lupus Erythematosus (cSLE) o
Externí odkaz:
https://doaj.org/article/baefd770f196419f87564974f3293b67